logo

For the Inventor, By the Inventor

Düsseldorf, Germany

Coley Pharmaceutical Gmbh


USPTO Granted Patents = 27

% Expired Patents = 55.6



Forward Citations = 934

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Jörg Vollmer (16 out of 17 patents)

silverMedal Arthur Mertz Krieg (13 out of 69 patents)

bronzeMedal Eugen Uhlmann (11 out of 80 patents)

4.  Marion Jurk (9 out of 10 patents)

5.  Grayson B Lipford (7 out of 23 patents)

6.  Ulrike Samulowitz (5 out of 5 patents)

7.  Gunther Hartmann (3 out of 19 patents)

8.  Harald Debelak (3 out of 6 patents)

9.  Hermann Wagner (3 out of 10 patents)

10.  Alexandra Forsbach (3 out of 3 patents)

11.  Stefan Bauer (2 out of 27 patents)

12.  Heather Lynn Davis (2 out of 16 patents)

13.  Robert L Bratzler (2 out of 6 patents)

14.  Robert Rankin (2 out of 2 patents)

15.  Charles M Zepp (1 out of 57 patents)


Core Competencies:
CpG Oligonucleotides
Immunostimulatory
RNA Sequence Motifs
Nucleic Acids
Toll-Like Receptor
Cancer Treatment
Adjuvant
Hepatitis C
Oligoribonucleotides
High Throughput Screening
Antibody-Induced Cell Lysis
C-Class Analogues

27 patents:

1. 10260071 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2019-04-16),
2. 9382545 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2016-07-05),
3. 8834900 - Combination motif immune stimulatory oligonucleotides with improved activity (2014-09-16),
4. 8580268 - CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity (2013-11-12),
5. 8466124 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2013-06-18),
6. 8354522 - Immunostimulatory oligoribonucleotides (2013-01-15),
7. 8304396 - Immunostimulatory nucleic acids (2012-11-06),
8. 8283328 - Immunostimulatory nucleic acids (2012-10-09),
9. 8227447 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2012-07-24),
10. 8202688 - Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant (2012-06-19),
11. 8198251 - Combination motif immune stimulatory oligonucleotides with improved activity (2012-06-12),
12. 8188254 - C-class oligonucleotide analogs with enhanced immunostimulatory potency (2012-05-29),
13. 8153141 - Immunostimulatory G, U-containing oligoribonucleotides (2012-04-10),
14. 8128944 - RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles (2012-03-06),
15. 7998492 - Methods and products related to treatment and prevention of hepatitis C virus infection (2011-08-16),
Company Overview
Coley Pharmaceutical GmbH, based in Düsseldorf, Germany, is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The organization specializes in harnessing the immune system to combat tumors, employing advanced technologies in immunotherapy and targeted drug delivery. With a commitment to research and development, Coley aims to address unmet medical needs in oncology, striving to improve patient outcomes through cutting-edge scientific advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

27 Patents

#27 in Düsseldorf

#1,739 in Germany

#24,034 in the World

Düsseldorf, DE
Düsseldorf, Germany

Coley Pharmaceutical Gmbh

Forward Citations = 934

24 inventors:

goldMedal Jörg Vollmer (16 out of 17 patents)

silverMedal Arthur Mertz Krieg (13 out of 69 patents)

bronzeMedal Eugen Uhlmann (11 out of 80 patents)

4.  Marion Jurk (9 out of 10 patents)

5.  Grayson B Lipford (7 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Coley Pharmaceutical Gmbh. Retrieved from https://idiyas.com/company/coley-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…